Metropolis Healthcare Limited

NSE METROPOLIS.NS

Metropolis Healthcare Limited Operating Income for the year ending March 31, 2024: USD 24.39 M

Metropolis Healthcare Limited Operating Income is USD 24.39 M for the year ending March 31, 2024, a -6.48% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Metropolis Healthcare Limited Operating Income for the year ending March 31, 2023 was USD 26.07 M, a -29.18% change year over year.
  • Metropolis Healthcare Limited Operating Income for the year ending March 31, 2022 was USD 36.82 M, a 9.41% change year over year.
  • Metropolis Healthcare Limited Operating Income for the year ending March 31, 2021 was USD 33.65 M, a 43.03% change year over year.
  • Metropolis Healthcare Limited Operating Income for the year ending March 31, 2020 was USD 23.53 M, a -11.91% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
SV Wall Street
NSE: METROPOLIS.NS

Metropolis Healthcare Limited

CEO Mr. Surendran Chemmenkotil
IPO Date April 15, 2019
Location India
Headquarters 250-D, Udyog Bhavan
Employees 4,313
Sector Healthcare
Industries
Description

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

Similar companies

INDIAMART.NS

IndiaMART InterMESH Limited

USD 23.82

-0.62%

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.88

-0.93%

ALKEM.NS

Alkem Laboratories Limited

USD 58.36

0.18%

NAVINFLUOR.NS

Navin Fluorine International Limited

USD 47.82

6.08%

THYROCARE.NS

Thyrocare Technologies Limited

USD 9.20

2.64%

StockViz Staff

February 3, 2025

Any question? Send us an email